Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3911 ARTÍCULOS , VIENDO DEL 1771 AL 1785

Preladenant as an Adjunctive Therapy With Levodopa in Parkinson Disease: Two Randomized Clinical Trials and Lessons Learned

Hauser RA, Stocchi F, Rascol O, Huyck SB, Capece R, Ho TW, Sklar P, Lines C, Michelson D, Hewitt D.

JAMA Neurol. 2015 Dec;72(12):1491-500. doi: 10.1001/jamaneurol.2015.2268.

[The use of piribedil in early and late stages of Parkinson's disease]

Fedorova NV, Kulua TK, Gubanova ЕN.

Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(10):96-98. doi: 10.17116/jnevro201511510196-98.

[A current view on dopamine receptor agonists in the treatment of Parkinson's disease]

Titova NV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(9):76-83. doi: 10.17116/jnevro20151159176-83.

Cell fate determination, neuronal maintenance and disease state: The emerging role of transcription factors Lmx1a and Lmx1b

Doucet-Beaupré H, Ang SL, Lévesque M.

FEBS Lett. 2015 Dec 21;589(24 Pt A):3727-38. doi: 10.1016/j.febslet.2015.10.020. Epub 2015 Oct 23.

Understanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson's disease

Haddad D, Nakamura K.

FEBS Lett. 2015 Dec 21;589(24 Pt A):3702-13. doi: 10.1016/j.febslet.2015.10.021. Epub 2015 Oct 23.

Monoamine transporters: insights from molecular dynamics simulations

Grouleff J, Ladefoged LK, Koldsø H, Schiøtt B.

Front Pharmacol. 2015 Oct 16;6:235. doi: 10.3389/fphar.2015.00235. eCollection 2015.

Recommended treatment strategies for patients with excessive daytime sleepiness

Rosenberg RP.

J Clin Psychiatry. 2015 Oct;76(10):e1330. doi: 10.4088/JCP.14019tx3c.

A fronto-striato-subthalamic-pallidal network for goal-directed and habitual inhibition

Jahanshahi M, Obeso I, Rothwell JC, Obeso JA.

Nat Rev Neurosci. 2015 Dec;16(12):719-32. doi: 10.1038/nrn4038. Epub 2015 Nov 4.

Parkinsonism-hyperpyrexia syndrome and deep brain stimulation

Artusi CA, Merola A, Espay AJ, Zibetti M, Romagnolo A, Lanotte M, Lopiano L.

J Neurol. 2015 Dec;262(12):2780-2. doi: 10.1007/s00415-015-7956-4. Epub 2015 Nov 3.

The association between Parkinson's disease and melanoma: a systematic review and meta-analysis

Huang P, Yang XD, Chen SD, Xiao Q.

Transl Neurodegener. 2015 Nov 3;4:21. doi: 10.1186/s40035-015-0044-y. eCollection 2015.

A Randomized Controlled Trial of Subcutaneous Apomorphine for Parkinson Disease: A Repeat Dose and Pharmacokinetic Study

Nomoto M, Kubo S, Nagai M, Yamada T, Tamaoka A, Tsuboi Y, Hattori N; PD Study Group.

Clin Neuropharmacol. 2015 Nov-Dec;38(6):241-7. doi: 10.1097/WNF.0000000000000111.

Recurrent and Alternating Pisa Syndrome

Pellene A, Saenz-Farret M, Micheli F.

Clin Neuropharmacol. 2015 Nov-Dec;38(6):252-4. doi: 10.1097/WNF.0000000000000113.

Safinamide (Addendum to Commission A15-18)

Institute for Quality and Efficiency in Health Care.

Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2015 Nov 5. Extract of Dossier Assessment No. A15-41.

Stem cells: An insight into the therapeutic aspects from medical and dental perspectives

Sivakumar M, Dineshshankar J, Sunil PM, Nirmal RM, Sathiyajeeva J, Saravanan B, Senthileagappan AR.

J Pharm Bioallied Sci. 2015 Aug;7(Suppl 2):S361-71. doi: 10.4103/0975-7406.163453.

Exploring Music-Based Rehabilitation for Parkinsonism through Embodied Cognitive Science

Schiavio A, Altenmüller E.

Front Neurol. 2015 Oct 19;6:217. doi: 10.3389/fneur.2015.00217. eCollection 2015.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias